anti-anthrax toxin polyclonal antibody-based vaccine (Buffalo BioDefense)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-anthrax toxin polyclonal antibody-based vaccine (Buffalo BioDefense)
Drug Alias NameTrithraxanti-anthrax toxin polyclonal antibody-based vaccine (Virionyx)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodiesVaccines > Application > Therapeutic vaccine
Mechanisms of ActionAntrax lethal toxin inhibitors
TargetsAntrax lethal toxin
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBuckler BioDefense Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBuckler BioDefense Inc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A